3 investments·1 product on Liners
Superorganism is a venture capital firm focused on backing early stage companies at the intersection of technology and biodiversity. The firm is led by experienced investors including co founder and managing director Kevin Webb, who has more than 15 years of venture and angel investing experience. Superorganism is based in the United States, with leadership in San Francisco and New York, as confirmed by public corporate profiles. Superorganism invests at the pre seed and seed stages, supporting startups that are “literally changing the world” through innovations that work with living systems. The firm backs technology enabled companies, including those applying artificial intelligence and advanced analytics, and its activity in Africa includes participation in pre seed and seed funding rounds. According to available investment data, Superorganism has invested in Amini AI, a Kenya based company building sovereign data infrastructure for local AI at scale, through multiple pre seed and seed rounds between May and November 2023. This activity reflects a focus on early stage AI and analytics solutions in Kenya. Superorganism explicitly positions biodiversity as a core investment theme and has pledged 10 percent of its profits to future conservation efforts. Through its strategy of funding companies that align technology with ecosystems and nature, Superorganism aims to translate biodiversity from an external consideration into a source of resilience and long term value. Its portfolio and messaging highlight a commitment to nature positive innovation supported by venture scale capital.
